LSE - Delayed Quote GBp
Genus plc (GNS.L)
1,606.00
-12.00
(-0.74%)
At close: 4:36:08 PM GMT+1
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
Baillie Gifford & Co -- | Annual Return | Oct 31, 2024 | 5,457,609 |
BlackRock Advisors (UK) Limited -- | Decrease | Apr 1, 2025 | 2,998,803 |
Capital Group Companies, Inc. -- | Annual Return | Oct 31, 2024 | 2,876,066 |
Devon Equity Management Ltd. -- | Annual Return | Oct 31, 2024 | 2,913,248 |
JNE Partners LLP -- | Holding | Dec 10, 2024 | 3,318,273 |
Kokke (Jorgen) -- | Exercise of Option | Feb 28, 2025 | 103,025 |
Low (Jim) -- | Sold | Apr 1, 2025 | 6,330 |
Royal London Asset Management Ltd -- | Annual Return | Oct 31, 2024 | 2,414,703 |
Scottish Widows Investment Partnership Ltd -- | Annual Return | Oct 31, 2024 | 4,288,880 |
Wellington Management Company, LLP -- | Annual Return | Oct 31, 2024 | 3,781,472 |
Related Tickers
ONTl.XC
TRX.L Tissue Regenix Group plc
36.40
-0.27%
RGLS Regulus Therapeutics Inc.
2.3000
+14.43%
SXTP 60 Degrees Pharmaceuticals, Inc.
2.7531
-12.88%
BMEA Biomea Fusion, Inc.
1.8900
+9.88%
NTLA Intellia Therapeutics, Inc.
8.25
+4.17%
VRTX Vertex Pharmaceuticals Incorporated
487.83
+2.16%
CRSP CRISPR Therapeutics AG
39.08
+3.33%
VKTX Viking Therapeutics, Inc.
25.36
+6.92%
MRNA Moderna, Inc.
25.39
+1.03%